ASE Technology Holding Co., Ltd. (ASX) | The Buildout — AI Infrastructure
The Verdict
ASE Technology Holding is a semiconductor assembly and test house with an electronics manufacturing services arm. It takes silicon wafers from foundries and turns them into packaged, tested chips ready for system integration. In the AI infrastructure buildout, its advanced packaging and test capacity sits at the bottleneck — as leading-edge chips become harder to produce, packaging and test capacity determines how many AI processors reach data centers.
| Market Cap | — |
| Revenue (TTM) | $22.8B |
| Revenue Growth | +17.7% |
| EBITDA Margin (TTM) | 20.1% |
| Net Debt | $5.9B |
| Earnings Beats | 5 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- LEAP advanced packaging grew from $0.6B in 2024 to $1.6B in 2025, and 2026 guidance tracks above $3.5B, with management aiming to double again in 2027.
- ATM was 66% of Q2 2026 consolidated revenue and 94% of operating profit, up from 61% and 87% a year earlier — a mix shift toward higher-margin assembly and test.
- Q2 ATM gross margin reached 27.3%, and fourth-quarter ATM gross margin is expected to exceed the 30% structural ceiling.
- General/mainstream growth was raised from 13% to roughly 20% for 2026, broadening demand beyond AI accelerators.
- 2026 capital spending now totals roughly $10.5B, with 70% of equipment CapEx for leading-edge services and 13 greenfield plus 7-8 brownfield projects.
What We’re Watching
- Execution risk: management says near-term growth is gated by its ability to install equipment and build facilities, with 13 greenfield and 7-8 brownfield projects running at once.
- Negative free cash flow: quarterly CapEx exceeds EBITDA, and management expects negative free cash flow to persist into 2027.
- Panel-level 310×310 line: fully automated production shifted from end-2026 to Q1 2027.
- Customer concentration: one unnamed customer was more than 10% of revenue in 2023, 2024, and 2025.
Thesis is strengthening. Demand exceeds supply, LEAP is tracking above $3.5B, ATM gross margin is expected to breach 30% in Q4, and mainstream demand is broadening beyond advanced packaging. The open question is whether ASE can execute the $10.5B capital program fast enough to convert visible demand into installed capacity without slippage.
Earnings Beat
Q2 2026 revenue was $6,000.6M, up 9.2% sequentially, with gross margin of 21.0%. Net income was $661.7M, flattered by NT$4.2B of mark-to-market equity gains and NT$1.5B of FX hedging gains. ATM revenue reached a record NT$126.1B, up 36% year over year, with ATM gross margin of 27.3%.
| Metric | Q2 FY2026 | Q1 FY2026 | Q2 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $6.0B | $5.5B | $4.9B | +23.0% |
| Gross margin | 21.0% | 20.1% | 16.1% | +490bps |
| EBITDA | $1.3B | $1.1B | $865M | +49.3% |
| EPS | $0.29 | $0.20 | $0.11 | +165.3% |
| ATM revenue | NT$126.1B | n/a | n/a | +36% YoY |
| ATM gross margin | 27.3% | n/a | n/a | +5.4 pp YoY |
The business demand is not a concern. It’s our own capability to execute.— Tien Wu, COO, 2026-07-30
Management tone: Management shifted from the February call's demand-and-ramp emphasis to a July call centered on capacity constraints: demand is not the concern, and execution is the bottleneck. The tone was confident on demand and margins, while management candidly discussed negative free cash flow and execution strain.
Management Guidance
For Q3, management guided consolidated revenue +21% to +22% QoQ, ATM revenue +11% to +13% QoQ, ATM gross margin 28% to 29%, EMS revenue roughly +40% QoQ, and EMS operating margin 3.2% to 3.4%. The stated Q3 consolidated gross margin range of 12.5% to 21.5% is flagged in the source as anomalous at the lower bound. For 2026, LEAP is tracking above $3.5B, ATM revenue is expected to grow about 35%, the general/mainstream segment about 20%, and total CapEx is roughly $10.5B; Q4 ATM gross margin is expected to exceed the 30% structural ceiling.
Trajectory
Quarterly revenue stepped from $5,537M in Q3 2025 to $6,001M in Q2 2026, through a Q1 dip of $5,494M. Gross margin expanded from 17.1% in Q3 2025 to 21.0% in Q2 2026, and EBITDA margin from 17.9% to 21.5%. The driver is ATM mix and utilization: advanced packaging demand exceeds supply, capacities are near full outside lines being installed, and Q4 ATM gross margin is expected above 30%. Cash conversion is the strain — trailing-twelve-month free cash flow to net income conversion is negative at -406% because CapEx exceeds EBITDA.
The Model
The model projects FY+1 revenue of $24,500M and EBITDA of $5,341M, a 21.8% margin, rising in FY+2 to revenue of $28,815M and EBITDA of $6,656M, a 23.1% margin. Near-term revenue is anchored by capacity-constrained ATM growth and LEAP revenue expected to add another couple of hundred million dollars above prior guidance; the FY+2 step assumes continued advanced-packaging demand and successful capacity additions.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $20.7B | $24.5B | $28.8B |
| YoY Growth | — | +18.6% | +17.6% |
| EBITDA | $3.8B | $5.3B | $6.7B |
| EBITDA Margin | 18.3% | 21.8% | 23.1% |
Projections are the median of 5 independent model runs. The model’s revenue sits 3.6% below analyst consensus.
For Q3, management guided consolidated revenue +21% to +22% QoQ, ATM revenue +11% to +13% QoQ, ATM gross margin 28% to 29%, EMS revenue roughly +40% QoQ, and EMS operating margin 3.2% to 3.4%. The stated Q3 consolidated gross margin range of 12.5% to 21.5% is flagged in the source as anomalous at the lower bound. For 2026, LEAP is tracking above $3.5B, ATM revenue is expected to grow about 35%, the general/mainstream segment about 20%, and total CapEx is roughly $10.5B; Q4 ATM gross margin is expected to exceed the 30% structural ceiling.
What Could Go Right — and Wrong
- Q4 2026 ATM gross margin exceeds 30% and management formally raises the structural margin range.
- 2027 LEAP doubling is formalized with a number and mix, extending the growth engine beyond the current-year guide.
- Full-process advanced packaging is expected to deliver substantial growth in 2027.
- Panel-level 310×310 automated line starts production in Q1 2027.
- General/mainstream demand sustains roughly 20% or better growth, confirming a broad AI upcycle.
- Execution slips on the 13 greenfield and 7-8 brownfield projects, delaying equipment installs and pushing revenue out.
- A major customer or foundry share shift, such as TSMC taking more advanced packaging in-house, hits LEAP directly.
- A demand pause before the current capacity wave is filled leaves new facilities underutilized while debt and depreciation rise.
- EMS weakness persists or memory component pass-through reverses, dragging consolidated revenue and the low-margin segment.
- Alternative packaging routes such as glass-substrate technologies gain share before ASE has a production position.
Looking Ahead
The next 12 months turn on execution and disclosure. Q4 2026 tests whether ATM gross margin breaks the 30% ceiling and whether the structural margin range is raised. In about two quarters from July 2026 — around Q1 2027 — management expects to provide a fuller 2027 LEAP breakdown and CPO revenue and 2027 outlook, and to have better clarity on 2027 CapEx. The fully automated 310×310 panel line is scheduled to start production in Q1 2027.
- Q4 2026ATM margin ceiling test — Whether Q4 ATM gross margin exceeds 30% and structural range is raised.
- Next quarter or so2027 CapEx clarity — Management expects better clarity on how much 2027 CapEx will require.
- Q1 20272027 LEAP breakdown — Fuller 2027 LEAP revenue, OS/full-process/others, and assembly/test split.
- Q1 2027310×310 panel line start — Fully automated panel-level packaging production expected to begin.
- About Q1 2027CPO revenue and outlook — Management defers CPO revenue and 2027 outlook roughly two quarters from July.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $18.5B | $20.7B | $22.8B | +11.4% |
| Gross Margin | 15.4% | 17.1% | 19.5% | +175bps |
| EBITDA | $3.1B | $3.8B | $28.8B | +22.9% |
| EBITDA Margin | 16.6% | 18.3% | 20.1% | +170bps |
| Net Income | $1.0B | $1.3B | $1.9B | +28.9% |
| Free Cash Flow | $170M | −$7.2B | −$4.0B | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)19.5%
- EBITDA Margin (TTM)20.1%
- Net Margin (TTM)8.5%
- ROIC9.7%
- FCF Conversion-172.1%
- SBC / Revenue0.0%
The Company
ASE Technology Holding is a leading provider of semiconductor manufacturing services in assembly and testing, with an adjacent electronics manufacturing services business. It packages chips across formats including flip chip BGA, QFN, 2.5D/3D, CoWoS, CPO, and tests wafers and finished devices. In the AI buildout, advanced packaging and test capacity is scarce, making ASE's role economically central.
It operates through ATM and EMS, the latter substantially through USI Group. In Q2 2026, ATM was 66% of consolidated revenue and 94% of operating profit. As of January 2026, the company listed 25,001 wire bonders, 7,456 testers, and 205 SMT lines, with sites including Kaohsiung, Penang, Singapore, and California.
Business Segments
Competitive Landscape
ASE's 20-F names TSMC as an advanced-packaging competitor, citing TSMC's InFO technology. Management framed full-process ambitions as co-optimization and second-source partnership with its foundry partner, saying 'We're not competing.' On U.S. expansion, the supplied material notes U.S. competitive pressure from Amkor and KYEC; management detailed existing Fremont and San Jose factories and expansion to #3 and #4 California factories while defending Taiwan-first manufacturing.
- TSMC20-F names TSMC as an advanced-packaging competitor, citing TSMC's InFO technology.
- AmkorAnalyst Q&A flagged U.S. competitive pressure from Amkor and KYEC; Joseph Tung expressed skepticism of U.S. packaging economics.
- KYECAnalyst Q&A also cited U.S. competitive pressure from KYEC; management defended a Taiwan-first manufacturing strategy.
Supply Chain
ASE sits between foundries and system builders, turning wafers into packaged, tested chips. Its 20-F names substrate suppliers, while most AI end-customer wiring is inferred rather than disclosed.
More on ASX: Earnings recap